The Indian startup ecosystem never truly sleeps. However, every once in a while, a week comes along that clearly signals momentum, confidence, and investor conviction. January 23 to January 29, 2026, was exactly that kind of week.
During this short yet eventful period, ₹1,250 Cr was raised across 19 deals, reinforcing one simple truth: capital continues to chase scale, defensibility, and category leadership.
More importantly, the top five deals alone accounted for a significant share of total capital deployed, giving us a sharp lens into where investors are placing their biggest bets right now.
So, let’s break it all down, calmly, clearly, and deal by deal.
A Quick Snapshot of the Week
Before diving into individual transactions, it’s worth stepping back and looking at the broader picture. After all, context makes numbers meaningful.
- Total amount raised: ₹1,250 Cr
- Number of deals: 19
- Time period: Jan 23 – Jan 29, 2026
In other words, while deal flow remained healthy, capital concentration was noticeably skewed toward larger, late-stage rounds, indicating a preference for businesses with proven traction.
Top 5 Funding Deals of the Week
To make things easier to absorb, here’s the complete data laid out cleanly:
| Deal Date | Trade Name | Deal Size (₹ Cr) | Investors / Buyers | Round / Series | Location |
| 23 Jan 2026 | Juspay | 458.20 | Westbridge Capital Partners | Series D | Bangalore |
| 29 Jan 2026 | Easy Home Finance | 275.85 | Investcorp | Claypond Capital | SMBC Asia Rising Fund | Series C | Mumbai |
| 27 Jan 2026 | SpotDraft | 73.41 | Qualcomm Ventures | Series B | Bengaluru |
| 28 Jan 2026 | Agrani Labs | 73.28 | Peak XV Partners (Sequoia India and SEA) | Seed | Bangalore |
| 27 Jan 2026 | Nivaan | 64.23 | Rebright Partners | Sorin Investments | W Health Ventures | Endiya Partners | Series A | New Delhi |
Note: All five deals are sourced from press announcements, as MCA filings are yet to be made.
Juspay: The Week’s Anchor Deal
To begin with, Juspay’s ₹458.20 Cr Series D stood tall as the largest transaction of the week.
Founded in 2012, Juspay has quietly become a backbone of India’s digital payments infrastructure; consequently, Westbridge Capital Partners’ continued backing signals long-term confidence in both scale and sustainability.
More importantly, this round wasn’t about survival capital. Instead, it was about deepening enterprise adoption, expanding payment intelligence, and strengthening global ambitions.
Simply put, this was growth capital, not defensive capital.
Easy Home Finance: Housing Credit Gets Institutional Muscle
Meanwhile, Easy Home Finance raised ₹275.85 Cr in a Series C, marking the second-largest deal of the week.
What stands out here is not just the amount, but the quality of investors:
- Investcorp
- Claypond Capital
- SMBC Asia Rising Fund
Together, these names reflect a strong institutional belief in India’s affordable housing finance opportunity, especially in underserved borrower segments.
Additionally, with incorporation dating back to 2017, Easy Home Finance sits at a stage where capital directly translates into balance-sheet expansion and loan book growth.
SpotDraft: Enterprise SaaS Continues to Deliver
Moving forward, SpotDraft’s ₹73.41 Cr Series B reinforces a familiar trend: enterprise SaaS remains investor-friendly when execution is strong.
Backed by Qualcomm Ventures, SpotDraft operates at the intersection of legal workflows and enterprise productivity. As a result, this round positions the company to double down on:
- Global customer acquisition
- Product depth
- AI-led contract automation
Notably, Bengaluru continues to be the epicenter for such SaaS success stories.
Agrani Labs: A Rare Deep-Tech Seed Signal
Equally important, Agrani Labs’ ₹73.28 Cr Seed round deserves special attention.
Incorporated as recently as April 2025, raising this quantum at the seed stage is far from ordinary. Backing from Peak XV Partners (Sequoia India & SEA) strongly suggests high conviction in Agrani’s R&D-heavy approach.
In a funding climate where seed capital is often cautious, this deal quietly highlights that deep science and defensible IP still command premium attention.
Nivaan (Rewind Healthcare): Capital Flows into Care Delivery
Finally, Nivaan’s ₹64.23 Cr Series A underlines a growing shift toward healthcare delivery platforms rather than just healthtech software.
With participation from Rebright Partners, Sorin Investments, W Health Ventures, and Endiya Partners, the round reflects confidence in:
- Patient-centric care models
- Scalable clinical operations
- Long-term healthcare demand
Based out of New Delhi, Nivaan represents a new wave of healthcare startups focusing on outcomes, not just interfaces.
What This Week Really Tells Us
When you zoom out, a few clear themes emerge:
- Late-stage capital remains highly active
- Strong fundamentals still attract premium cheques
- SaaS, fintech infrastructure, housing finance, healthcare, and deep-tech are all alive and well
- Capital is selective, but decisive
In short, this wasn’t a noisy funding week; it was a confident one.
Conclusion
As capital continues to flow into quality businesses, tracking verified, structured deal intelligence becomes more critical than ever.
PrivateCircle helps investors, founders, and advisors stay ahead with real-time private market data, deal tracking, and ownership insights, all in one place.